Literature DB >> 21615797

What causes type 1 diabetes? Lessons from animal models.

Karsten Buschard1.   

Abstract

To study type 1 diabetes (T1D), excellent animal models exist, both spontaneously diabetic and virus-induced. Based on knowledge from these, this review focuses on the environmental factors leading to T1D, concentrated into four areas which are: (1) The thymus-dependent immune system: T1D is a T cell driven disease and the beta cells are destroyed in an inflammatory insulitis process. Autoimmunity is breakdown of self-tolerance and the balance between regulator T cells and aggressive effector T cells is disturbed. Inhibition of the T cells (by e.g. anti-CD3 antibody or cyclosporine) will stop the T1D process, even if initiated by virus. Theoretically, the risk from immunotherapy elicits a higher frequency of malignancy. (2) The activity of the beta cells: Resting beta cells display less antigenicity and are less sensitive to immune destruction. Beta-cell rest can be induced by giving insulin externally in metabolic doses or by administering potassium-channel openers. Both procedures prevent T1D in animal models, whereas no good human data exist due to the risk of hypoglycemia. (3) NKT cells: According to the hygiene hypothesis, stimulation of NKT cells by non-pathogen microbes gives rise to less T cell reaction and less autoimmunity. Glycolipids presented by CD1 molecules are central in this stimulation. (4) Importance of the intestine and gliadin intake: Gluten-free diet dramatically inhibits T1D in animal models, and epidemiological data are supportive of such an effect in humans. The mechanisms include less subclinical intestinal inflammation and permeability, and changed composition of bacterial flora, which can also be obtained by intake of probiotics. Gluten-free diet is difficult to implement, and short-term intake has no effect. Regarding the onset of the T1D disease process, slow-acting enterovirus and gliadin deposits are speculated to be etiological in genetically susceptible individuals, followed by the mentioned four pathogenetic factors acting in concert. Neutralization of any one of these factors is capable of stopping T1D development, as lessons are learned from the animal models.
© 2011 The Author. APMIS © 2011 APMIS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615797     DOI: 10.1111/j.1600-0463.2011.02765.x

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


  10 in total

1.  Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.

Authors:  Anne Jörns; Tanja Arndt; Andreas Meyer zu Vilsendorf; Jürgen Klempnauer; Dirk Wedekind; Hans-Jürgen Hedrich; Lorella Marselli; Piero Marchetti; Nagakatsu Harada; Yutaka Nakaya; Gen-Sheng Wang; Fraser W Scott; Conny Gysemans; Chantal Mathieu; Sigurd Lenzen
Journal:  Diabetologia       Date:  2013-12-06       Impact factor: 10.122

2.  A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice.

Authors:  E H Adlercreutz; C Weile; J Larsen; K Engkilde; D Agardh; K Buschard; J C Antvorskov
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

3.  Large Gliadin Peptides Detected in the Pancreas of NOD and Healthy Mice following Oral Administration.

Authors:  Susanne W Bruun; Knud Josefsen; Julia T Tanassi; Aleš Marek; Martin H F Pedersen; Ulrik Sidenius; Martin Haupt-Jorgensen; Julie C Antvorskov; Jesper Larsen; Niels H Heegaard; Karsten Buschard
Journal:  J Diabetes Res       Date:  2016-10-04       Impact factor: 4.011

4.  Gluten-Free Diet Only during Pregnancy Efficiently Prevents Diabetes in NOD Mouse Offspring.

Authors:  Julie C Antvorskov; Knud Josefsen; Martin Haupt-Jorgensen; Petra Fundova; David P Funda; Karsten Buschard
Journal:  J Diabetes Res       Date:  2016-08-25       Impact factor: 4.011

5.  A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses.

Authors:  Niila V V Saarinen; Jutta E Laiho; Sarah J Richardson; Marie Zeissler; Virginia M Stone; Varpu Marjomäki; Tino Kantoluoto; Marc S Horwitz; Amirbabak Sioofy-Khojine; Anni Honkimaa; Minna M Hankaniemi; Malin Flodström-Tullberg; Heikki Hyöty; Vesa P Hytönen; Olli H Laitinen
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

6.  A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates.

Authors:  V M Stone; M M Hankaniemi; O H Laitinen; A B Sioofy-Khojine; A Lin; I M Diaz Lozano; M A Mazur; V Marjomäki; K Loré; H Hyöty; V P Hytönen; M Flodström-Tullberg
Journal:  Sci Adv       Date:  2020-05-06       Impact factor: 14.136

Review 7.  Environmental Triggering of Type 1 Diabetes Autoimmunity.

Authors:  Pamela Houeiss; Sandrine Luce; Christian Boitard
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

8.  Gliadin fragments and a specific gliadin 33-mer peptide close KATP channels and induce insulin secretion in INS-1E cells and rat islets of langerhans.

Authors:  Morten Dall; Kirstine Calloe; Martin Haupt-Jorgensen; Jesper Larsen; Nicole Schmitt; Knud Josefsen; Karsten Buschard
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

9.  Moderate Intensity Training Impact on the Inflammatory Status and Glycemic Profiles in NOD Mice.

Authors:  Roberto Codella; Giacomo Lanzoni; Alessia Zoso; Andrea Caumo; Anna Montesano; Ileana M Terruzzi; Camillo Ricordi; Livio Luzi; Luca Inverardi
Journal:  J Diabetes Res       Date:  2015-08-05       Impact factor: 4.011

10.  Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.

Authors:  Elke Gülden; Masaru Ihira; Atsushi Ohashi; Anna Lena Reinbeck; Marina A Freudenberg; Hubert Kolb; Volker Burkart
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.